Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-65,939
Closed -$10M 3737
2026
Q1
$10M Sell
65,939
-477,309
-88% -$72.4M ﹤0.01% 1188
2025
Q4
$57.8M Buy
+543,248
New +$61M 0.01% 583
2025
Q3
Sell
-872,730
Closed -$73.8M 2339
2025
Q2
$73.8M Sell
872,730
-142,577
-14% -$9.62M 0.01% 601
2025
Q1
$59.5M Buy
1,015,307
+532,944
+110% +$42.9M 0.02% 650
2024
Q4
$39M Sell
482,363
-4,243
-0.9% -$334K 0.01% 724
2024
Q3
$38.9M Buy
486,606
+67,250
+16% +$6.56M 0.01% 733
2024
Q2
$52.5M Buy
+419,356
New +$40M 0.02% 608

Other funds holding CAMT

UBS AM's CAMT Position: Q2 2026 in Review

UBS AM sold out of Camtek (CAMT) in Q2 2026, closing a stake of 65,939 shares — an estimated $10M sold.

UBS AM first reported a position in CAMT in Q2 2024 and held it in 7 quarters. The position peaked at $73.8M in Q2 2025. 235 funds tracked by Wall St. Rank hold CAMT as of Q2 2026.

  • UBS AM reported no remaining Camtek position as of Q2 2026 after selling out during the quarter.
  • UBS AM sold 65,939 Camtek shares in Q2 2026, an estimated $10M.
  • UBS AM first reported a position in Camtek in Q2 2024 and held it in 7 quarters.
  • UBS AM's Camtek position peaked at $73.8M in Q2 2025.
  • 235 funds tracked by Wall St. Rank held Camtek as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.